ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 61 filers reported holding ESSA PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,463,288 | +15.6% | 473,556 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $1,266,305 | +101611.2% | 469,002 | +11.9% | 0.00% | 0.0% |
| Q1 2023 | $1,245 | +183.0% | 419,067 | +140.2% | 0.00% | – |
| Q4 2022 | $440 | -99.9% | 174,475 | -57.1% | 0.00% | – |
| Q3 2022 | $740,000 | -28.1% | 406,761 | +24.5% | 0.00% | -100.0% |
| Q2 2022 | $1,029,000 | -17.6% | 326,730 | +61.7% | 0.00% | 0.0% |
| Q1 2022 | $1,249,000 | -35.1% | 202,047 | +49.1% | 0.00% | 0.0% |
| Q4 2021 | $1,925,000 | -3.2% | 135,550 | -45.5% | 0.00% | 0.0% |
| Q3 2021 | $1,989,000 | +211.8% | 248,687 | +1014.3% | 0.00% | – |
| Q2 2021 | $638,000 | -45.0% | 22,318 | -44.2% | 0.00% | -100.0% |
| Q1 2021 | $1,161,000 | +138.9% | 39,969 | -2.0% | 0.00% | – |
| Q4 2020 | $486,000 | +11.7% | 40,769 | -35.3% | 0.00% | -100.0% |
| Q3 2020 | $435,000 | – | 62,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |